dexamethasone,mezigdomide
bms
['mm-001', 'mezigdomide', 'mmsm', 'multiple myeloma', 'cc-92480', 'dexamethasone']
efficacy and safety were positive findings in the phase 1/2 cc-92480-mm-001 trial when mezigdomide was added to dexamethasone in patients with heavily pretreated multiple myeloma. #mmsm #ash22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.